DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

If you want to monitor your vital signs like an Olympic athlete, or just someone watching their weight, it will become easier in a few months. Glucose-monitor vendor DexCom announced a pairing ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

Oura and Dexcom have announced a strategic partnership Dexcom data will be visible inside Oura's application Dexcom says it will invest $75 million in Oura's Series D funding ...

the Dexcom G7 Continuous Glucose Monitoring (CGM) System, will be added to the Régie de l'assurance maladie du Québec (RAMQ) Public Prescription Drug Insurance Plan. Québec residents living ...

you should welcome a pact between glucose-monitor vendor DexCom and Oura smart rings. Here's How Much $100 In Bitcoin Could Be Worth In 2030 If Cathie Wood's Price Target Is Reached The Wall ...

Dexcom and ŌURA announce a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart ...

Dexcom continues to offer its leading CGM systems, along with Stelo, its recently launched over-the-counter glucose biosensor. Combining its OTC CGM offering with the retail-available Oura Ring ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM ... Both companies also sell reimbursable prescription CGMs for type 1 and type 2 diabetes ...

People without diabetes can choose between the two continuous glucose monitors cleared by the FDA. The agency approved the first CGM for over-the-counter use in March. Stelo, by Dexcom ...